Skip to main content
Navigate Up
Sign In
 

No Greater Amputation Risk with Canagliflozin in T2D Patients


“I think this is to some extent reassuring,” commented Robert Eckel, of the CU Anschutz Medical Campus. Eckel, who was not involved with the study, cautioned that a randomized clinical trial is needed to confirm these observed findings.

Read more